Suven Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '23
Sep '23
Jun '23
Mar '23
Dec '22
Total Qtr Revenue cr
234.16
250.90
358.22
380.76
366.78
Other Income Qtr Cr14.3419.8410.6711.4013.01
Operating Revenues Qtr219.82231.05347.55369.36353.77

*All values are in Cr.

Operating Expenses Qtr
154.68
133.09
180.58
200.28
207.08
Operating Profit Qtr
65.14
97.96
166.97
169.08
146.69
EBIDT Qtr Cr
79.49
117.80
177.63
180.48
159.71
Depreciation Qtr
12.75
11.89
12.54
11.96
12.24
Net Profit Qtr
46.75
79.56
120.59
123.97
107.72
Basic EPS Qtr
1.84
3.13
4.74
4.87
4.23
Open Demat Account
or Resume your Application
+91 -

personImage